Coloplast A/S (OTCMKTS:CLPBY) Upgraded by Kepler Capital Markets to “Strong-Buy” Rating

Coloplast A/S (OTCMKTS:CLPBY) was upgraded by Kepler Capital Markets to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.

Other equities research analysts have also recently issued reports about the stock. Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold”.

Coloplast A/S Trading Up 2.6%

CLPBY stock opened at $6.62 on Wednesday. Coloplast A/S has a one year low of $6.10 and a one year high of $10.03. The company has a market capitalization of $14.91 billion, a PE ratio of 47.26, a price-to-earnings-growth ratio of 2.04 and a beta of 0.15. The company’s 50 day moving average price is $6.61 and its two-hundred day moving average price is $7.83. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. The company had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. As a group, analysts predict that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.